Streetbeat News

AKU

Akumin Inc

Employees

351

Industry

Diagnostic Imaging Centers

we believe there’s a smarter approach to good health. by combining our clinical expertise with the latest advances in technology and information systems, we’re developing a service that provides insightful and useful clinical information to referring physicians. through this collaboration, we can help patients learn more about their health risks and predispositions, and progress from simply diagnosing diseases to actually preventing them. join us as we introduce a new kind of healthcare experience.

Open

0.32

Mkt cap

26M

Volume

7.9M

High

0.35

P/E Ratio

-0.13

52-wk high

1.90

Low

0.28

Div yield

N/A

52-wk low

0.12

Akumin Inc. announced leadership changes with Krishna Kumar appointed as CEO, succeeding Riadh Zine. Chandra Westergaard is named General Counsel. The company aims for growth and innovation in radiology and oncology services.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 10:08 pm

U.S. stocks traded mixed with the Nasdaq Composite gaining over 100 points. Energy shares dipped by 1.9% while communication services shares rose by 1.3%. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw significant gains after strategic collaborations and acquisitions. Li-Cycle Holdings Corp., Revolution Medicines, and Apollomics, Inc. saw significant drops due to halted projects and clinical trial data. Oil traded down 2.6% to $85.79.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 6:39 pm

The Nasdaq Composite gained over 60 points on Monday, with communication services shares rising by 0.9%. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw significant increases in their share prices due to strategic collaborations and acquisitions. However, Li-Cycle Holdings Corp., Revolution Medicines, and Apollomics saw a decrease in their share prices due to halted projects and clinical trial data.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 4:06 pm

Akumin Inc. has announced an agreement with Stonepeak to transition into a private company. This news has led to a rise in Akumin's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 3:04 pm

Akumin Inc. (NASDAQ:AKU) has reached an agreement with Stonepeak to become a private company. The deal involves the cancellation and conversion of an existing Stonepeak note worth approximately $470 million into shares of Akumin. Stonepeak will also invest $130 million in new capital into Akumin. The transaction will be implemented through a prepackaged court-supervised process and is expected to be approved within 45 days. Akumin's operations will continue as normal during this period.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 2:43 pm

US stocks traded lower with the Dow Jones index falling over 100 points. The Chicago Fed National Activity Index increased to +0.02 in September from -0.22 in the prior month. LumiraDx Limited, INVO Bioscience, and Akumin Inc. saw their shares rise after various strategic collaborations and agreements. Li-Cycle Holdings Corp., Revolution Medicines, and XORTX Therapeutics saw their shares drop due to halted projects and clinical trial data.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 1:43 pm

The article lists the top gainers and losers in pre-market trading. LumiraDx Limited's shares surged after a strategic collaboration with AstraZeneca and Everton. Akumin Inc. rose after an agreement with Stonepeak to go private. Textainer Group Holdings Limited gained after agreeing to be acquired by Stonepeak. Harpoon Therapeutics, Inc. climbed after disclosing updated interim data from a clinical trial. Roivant Sciences Ltd. rose after Roche agreed to acquire Telavant. Troika Media Group, Inc. fell after reporting financial results. XORTX Therapeutics Inc. dipped after a significant jump on Friday.

Portfolio Pulse from Lisa Levin

October 23, 2023 | 11:32 am

Akumin, a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, identified suspicious activity in its IT network on October 11, which was the result of a ransomware incident. This disrupted the company's ability to provide services to its business partners. However, the company resumed treating some patients on October 13.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 9:06 pm

Several stocks have seen significant movement in pre-market trading. Notably, Palo Alto Networks, Inc. (NASDAQ:PANW) shares rose by 12.3% following better-than-expected Q4 earnings and a strong billings outlook. Other gainers include China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC), Tian Ruixiang Holdings Ltd (NASDAQ:TIRX), and Adial Pharmaceuticals, Inc. (NASDAQ:ADIL). On the other hand, Super League Gaming, Inc. (NASDAQ:SLGG) and Napco Security Technologies, Inc. (NASDAQ:NSSC) shares fell significantly.

Portfolio Pulse from Lisa Levin

August 21, 2023 | 12:32 pm

The article lists the stocks that have gained and lost the most in Thursday's mid-day session. Among the gainers, PhenomeX Inc. surged 138.3% after Bruker Corporation announced plans to acquire it. Tivic Health Systems jumped 39.1% after starting enrollment for a study on its non-invasive bioelectronic device. Among the losers, Creative Realities fell 35.6% after pricing its public offering of common stock, and EMCORE Corporation also fell 35.6% after pricing its public offering.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 4:26 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.